• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimistic

2

‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billion

3

Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyard

1

'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimistic

2

‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billion

3

Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyard
Health

The psychology behind why people will take horse paste, but not COVID vaccines

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
September 2, 2021, 5:30 PM ET
Add Fortune on Google for similar content.

Say you’re in the midst of an unprecedented global pandemic. To protect yourself, you have a choice between vaccines that were tested on tens of thousands of people in rigorous clinical trials specifically for the purpose of combating COVID-19, or a decades-old drug like ivermectin that is most commonly known as a powerful parasite fighting treatment, often used for horses and livestock.

One option has been endorsed by scientists, regulators, academic institutions, public health experts, and government leaders alike and proved remarkably effective as vaccines have been doled out to billions of people across the world less than a year into the outbreak; the other has a handful of approved uses in humans but no robust clinical evidence that it works against coronavirus illness, a fact the aforementioned experts repeatedly raise while warning against its off-label use for COVID. Which one of these would you take? And, more importantly if you’re going the equine dewormer route, why?

It’s a head-scratcher as a small but growing number of Americans—many of them from the anti-vaxxer or vaccine skeptic crowd—have pushed demand for ivermectin prescriptions (and the version for animals) into high gear over the past few months. This medical counterculture harbors an abiding belief that the efficacy and safety of COVID vaccines is overblown as well as a mistrust of pharmaceutical companies, government officials, and media narratives around the pandemic. The politicization of COVID public health efforts certainly doesn’t help matters since ideology is one of the strongest indicators of whether or not someone is a COVID vaccine skeptic. There were usually about 3,600 ivermectin prescriptions issued weekly in the U.S. prior to the pandemic; by mid-August, that number had jumped to 88,000 per week.

This is despite the fact that the Food and Drug Administration (FDA), the World Health Organization (WHO), and the very maker of ivermectin itself, pharma giant Merck, have all urged people not to go out and take large amounts of a livestock-focused drug to stop the coronavirus given the sheer lack of evidence it works and the very real risks of overdoses and hospitalization (the WHO recommends against any type of COVID-related ivermectin use outside of a clinical trial). The FDA is a bit more blunt and points out that ivermectin isn’t even meant to fight viruses.

“FDA has not approved ivermectin for use in treating or preventing COVID-19 in humans. Ivermectin tablets are approved at very specific doses for some parasitic worms, and there are topical (on the skin) formulations for head lice and skin conditions like rosacea. Ivermectin is not an anti-viral (a drug for treating viruses),” the agency says, noting reports of more people landing in the hospital from ivermectin overdoses. (It turns out your typical human shouldn’t take similar doses of a treatment as what’s given to a 1,000 pound horse.)

Mistrust in institutions and mainstream narratives is nothing new among certain slices of the populace. But why pair that mistrust with advocating for a completely different drug? Scottish psychologist and public health communicator Stuart Ritchie, a lecturer at King’s College London, has a fairly simple assessment of what’s driving the current ivermectin frenzy, much like the clamoring over hydroxychloroquine, an unproven treatment for COVID touted by former President Donald Trump.

“The reason for the double-standard is obvious: contrarianism. Treatments such as ivermectin (and hydroxychloroquine and Vitamin D) have never had mainstream approval, or the nod from U.K. or U.S. medical regulators for their use against COVID,” he wrote in a recent column for the NewStatesman. “The contrarians can get excited about the apparently dramatic effects of ivermectin without having to agree with people they regard as wildly wrong on case rates, death rates, the effects of lockdowns, and so on. They also get to feel the frisson of telling the world that they know better: they have secret knowledge about a super-important treatment, and the blinkered medical community just won’t listen.”

Numerous studies delving into the psychology of vaccine skeptics pick up on this contrarian bent, including significant evidence that presenting facts and data to anti-vaxxers typically makes them double down on their scientifically invalidated positions. It turns out that same quirk of psychology can also lead some people to champion an obscure animal drug in an act of epistemological defiance, especially when they can point to validation from politically charged organizations like America’s Frontline Doctors and the social media feeds of like-minded people.

The ivermectin-for-coronavirus crowd is still a pretty small slice of the population. But it’s a vocal one with the ability to reach millions of people via social media and drive unnecessary hospitalizations from overdoses in a moment when ICUs are already at the breaking point from treating COVID patients.

Subscribe to Fortune Daily to get essential business stories straight to your inbox each morning.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Ferran Torres
SuccessWorld Cup
Spain’s Ferran Torres scored the winning goal in the World Cup—but just four years ago, he was in therapy and stuck in a ‘bottomless pit’
By Emma BurleighJuly 20, 2026
6 hours ago
FDA walks back positive lab test while lettuce recall continues
HealthFood and drink
FDA walks back positive lab test while lettuce recall continues
By Bloomberg, Kristina Peterson, Jessica Nix and Daniela SirtoriJuly 20, 2026
7 hours ago
Pharmacy technician Brandy Leroy fills a TPN bag using the ExactaMix Pro Automated Compounding System
Startups & VentureTerm Sheet
The FDA’s peptide vote could create telehealth’s next multibillion-dollar market
By Lily Mae LazarusJuly 20, 2026
10 hours ago
A decade after the ‘Godfather of AI’ said radiologists were obsolete, their salaries are up to $571K and demand is growing fast
AIthe future of work
A decade after the ‘Godfather of AI’ said radiologists were obsolete, their salaries are up to $571K and demand is growing fast
By Marco Quiroz-GutierrezJuly 19, 2026
1 day ago
How United’s ‘premiumization’ strategy got passengers to swallow higher airfares without a fight
HealthAirline industry
How United’s ‘premiumization’ strategy got passengers to swallow higher airfares without a fight
By Phil WahbaJuly 19, 2026
2 days ago
Diarrhea-causing lettuce may have spread as wide as 27 states, Taylor Farms recall suggests
HealthFood and drink
Diarrhea-causing lettuce may have spread as wide as 27 states, Taylor Farms recall suggests
By Savannah Peters and The Associated PressJuly 18, 2026
2 days ago

Most Popular

'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimistic
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimistic
By Jason MaJuly 18, 2026
2 days ago
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billion
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billion
By Sydney LakeJuly 20, 2026
8 hours ago
Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyard
AI
Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyard
By Aaron Walayat and The ConversationJuly 19, 2026
2 days ago
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stock
Success
Mark Cuban says he has the solution to growing income inequality, and it's to reward every employee—from CEO to janitor—with company stock
By Sasha RogelbergJuly 20, 2026
4 hours ago
Red Lobster’s 37-year-old CEO waited tables before joining the C-suite—he says it was a crash course in managing ‘difficult people and situations’
Success
Red Lobster’s 37-year-old CEO waited tables before joining the C-suite—he says it was a crash course in managing ‘difficult people and situations’
By Preston ForeJuly 19, 2026
2 days ago
Warren Buffett says his $147 billion investing career was an accident: ‘I may be one of the 10 luckiest in the world’
Future of Work
Warren Buffett says his $147 billion investing career was an accident: ‘I may be one of the 10 luckiest in the world’
By Sarah GlodekJuly 20, 2026
15 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.